Multi-omics analyses of cancer-linked clinical salmonellae reveal bacterial-induced host metabolic shift and mTOR-dependent cell transformation.

Jacques Neefjes, Janneke W Duijster, Virginie Stévenin, Claudia E Coipan, Daphne M van Elsland, Linda Voogd, Lise Bigey, Angela H A M van Hoek, Lucas M Wijnands, Lennert Janssen, Jimmy J L L Akkermans, Andra Neefjes-Borst, Eelco Franz, Lapo Mughini-Gras

Journal: Cell reports 2024;43(11):114931

PMID: 39488829

Abstract

Salmonellae are associated epidemiologically and experimentally with colon cancer. To understand how Salmonella induces cell transformation, we performed multi-omics and phenotypic analyses of Salmonella clinical strains isolated from patients later diagnosed with colon cancer (case strains) and control strains from patients without cancer. We show that high transformation efficiency is a frequent intrinsic feature of clinical (case and control) salmonellae, yet case strains showed higher transformation efficiency than control strains. Transformation efficiency correlates with gene expression, nutrient utilization, and intracellular virulence, but not with genetic features, suggesting a phenotypic convergence of Salmonella strains resulting in cell transformation. We show that both bacterial entry and intracellular replication are required for host cell transformation and are associated with hyperactivation of the mTOR pathway. Strikingly, transiently inactivating mTOR through chemical inhibition reverses the transformation phenotype instigated by Salmonella infection. This suggests that targeting the mTOR pathway could prevent the development of Salmonella-induced tumors.

Copyright © 2024 The Author(s). Published by Elsevier Inc. All rights reserved.

Address: Department of Cell and Chemical Biology, Oncode Institute, Leiden University Medical Center (LUMC), 2333 ZC Leiden, the Netherlands. Electronic address: [email protected].; Center for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), 3721 MA Bilthoven, the Netherlands.; Department of Cell and Chemical Biology, Oncode Institute, Leiden University Medical Center (LUMC), 2333 ZC Leiden, the Netherlands.; Department of Cell and Chemical Biology, Oncode Institute, Leiden University Medical Center (LUMC), 2333 ZC Leiden, the Netherlands; École Normale Supérieure Paris-Saclay, 91190 Gif-sur-Yvette, France.; Pathology Department, Amsterdam University Medical Center (VUmc), 1081 HV Amsterdam, the Netherlands.; Center for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), 3721 MA Bilthoven, the Netherlands; Institute for Risk Assessment Sciences, Utrecht University, 3584 CM Utrecht, the Netherlands.; Department of Cell and Chemical Biology, Oncode Institute, Leiden University Medical Center (LUMC), 2333 ZC Leiden, the Netherlands. Electronic address: [email protected].

Link outs

Subscription / membership required

Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.